Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-1.47 Insider Own0.38% Shs Outstand124.91M Perf Week-1.64%
Market Cap1.72B Forward P/E- EPS next Y-1.45 Insider Trans2.16% Shs Float124.45M Perf Month-24.06%
Income-182.80M PEG- EPS next Q-0.57 Inst Own100.00% Short Float13.28% Perf Quarter-25.46%
Sales185.10M P/S9.31 EPS this Y23.20% Inst Trans-1.62% Short Ratio5.48 Perf Half Y-54.93%
Book/sh2.12 P/B6.50 EPS next Y66.70% ROA-68.80% Target Price50.14 Perf Year-57.05%
Cash/sh2.06 P/C6.70 EPS next 5Y22.50% ROE-78.60% 52W Range12.77 - 41.20 Perf YTD-54.20%
Dividend- P/FCF- EPS past 5Y-36.60% ROI-67.00% 52W High-67.25% Beta3.70
Dividend %- Quick Ratio6.00 Sales past 5Y91.10% Gross Margin94.40% 52W Low5.66% ATR0.95
Employees420 Current Ratio6.10 Sales Q/Q87.20% Oper. Margin- RSI (14)36.36 Volatility9.74% 5.68%
OptionableYes Debt/Eq0.00 EPS Q/Q8.30% Profit Margin- Rel Volume0.88 Prev Close13.79
ShortableYes LT Debt/Eq0.00 EarningsAug 08 AMC Payout- Avg Volume3.01M Price13.49
Recom2.00 SMA20-11.06% SMA50-16.13% SMA200-41.60% Volume260,804 Change-2.15%
Aug-09-18Reiterated Stifel Hold $17 → $14
Aug-07-18Initiated Stifel Hold $17
Aug-06-18Downgrade Piper Jaffray Overweight → Neutral
Oct-06-17Resumed Goldman Neutral
Nov-11-16Initiated Goldman Neutral
Nov-08-16Upgrade BofA/Merrill Neutral → Buy
Oct-19-16Resumed ROTH Capital Neutral
Oct-04-16Initiated Leerink Partners Mkt Perform $34
Jun-22-16Downgrade BofA/Merrill Buy → Neutral
May-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Mar-30-16Reiterated Piper Jaffray Overweight $39 → $44
Feb-08-16Initiated BofA/Merrill Buy $40
Jan-22-16Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Feb-24-15Initiated H.C. Wainwright Buy $50
Feb-06-15Resumed ROTH Capital Buy $42
Aug-15-18 06:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD ACCESSWIRE
05:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, HAIR and ACAD GlobeNewswire
09:36AM  INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against ACADIA Pharmaceuticals Inc. Business Wire
Aug-14-18 05:20PM  ACAD NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. ACAD GlobeNewswire
03:50PM  Edited Transcript of ACAD earnings conference call or presentation 8-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-13-18 01:00PM  CLASS ACTION UPDATE for FPI, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:05AM  Kessler Topaz Meltzer & Check, LLP Reminds ACADIA Pharmaceuticals Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit ACCESSWIRE
10:55AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD ACCESSWIRE
07:10AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD ACCESSWIRE
Aug-12-18 11:45AM  SHAREHOLDER ALERT: MRCY GLNCY GLCNF MD FPI FIZZ SBGL ACAD ABBV TTPH RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Aug-11-18 08:00AM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline  ACAD GlobeNewswire
Aug-10-18 10:50PM  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD Business Wire +7.26%
12:30PM  SHAREHOLDER ALERT: UNM SBGL PCG ACAD RMTI TTPH FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:40AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) and Lead Plaintiff Deadline: September 17, 2018 ACCESSWIRE
Aug-09-18 05:13PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GLNCY, GLCNF, ORA, FPI, ACAD and RMTI GlobeNewswire
03:05PM  IMPORTANT DEADLINE ALERT The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
09:00AM  Why Acadia Pharmaceuticals Stock Is Tanking Today Motley Fool
Aug-08-18 08:30PM  Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Lags Revenue Estimates Zacks
05:41PM  SHAREHOLDER ALERT: HAIR TAL UNM ORA NWL PCG FLKS ACAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
05:15PM  ACADIA SHAREHOLDER ALERT: Block & Leviton Reminds Investors of Securities Class Action Filed Against ACADIA Pharmaceuticals, Inc. (ACAD); Shareholders Are Encouraged to Contact The Firm ACCESSWIRE
04:06PM  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Acadia Pharmaceuticals Inc. Investors GlobeNewswire
04:05PM  ACADIA Pharmaceuticals Reports Second Quarter 2018 Financial Results Business Wire
03:00PM  ACADIA Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
10:10AM  Q2 Earnings Preview For ACADIA Pharmaceuticals Benzinga
Aug-07-18 01:21PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NWL, GOGO and ACAD GlobeNewswire
Aug-06-18 11:40PM  Pawar Law Group Announces Investigation of Securities Claims Against ACADIA Pharmaceuticals Inc. - ACAD ACCESSWIRE -8.61%
07:10PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Pharmaceuticals, Inc. To Contact The Firm Business Wire
05:16PM  ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement for the North American Development and Commercialization of Trofinetide in Rett Syndrome Business Wire
04:52PM  CLASS ACTION UPDATE for MRCY, GLNCY, GLCNF, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:30PM  IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD ACCESSWIRE
12:16PM  SHAREHOLDER ALERT: MD ORA SBGL NWL PCG ACAD RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
08:18AM  ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets downgraded to Neutral by Piper Jaffray Companies Market Exclusive
Aug-04-18 11:00AM  ACAD ALERT NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc.; Investor Deadline ACAD Business Wire
Aug-03-18 10:50PM  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD GlobeNewswire
06:54PM  Pomerantz Law Firm Announces the Filing of a Class Action against ACADIA Pharmaceuticals Inc. and Certain Officers ACAD GlobeNewswire
04:32PM  Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline GlobeNewswire
02:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SBGL, ACAD and HMNY GlobeNewswire
12:10PM  Pawar Law Group Announces Investigation of Securities Claims Against ACADIA Pharmaceuticals Inc. - ACAD ACCESSWIRE
10:15AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) and Lead Plaintiff Deadline - September 17, 2018 ACCESSWIRE
Aug-02-18 10:22AM  SHAREHOLDER ALERT: MD ANW QCOM FIZZ NWL GOGO ACAD FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:06AM  INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ACADIA Pharmaceuticals Inc. - ACAD ACCESSWIRE
Aug-01-18 08:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Pharmaceuticals Inc. - ACAD ACCESSWIRE
05:46PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MabVax, Farmland, and ACADIA, and Encourages Investors to Contact the Firm GlobeNewswire
11:00AM  SHAREHOLDER ALERT: MD ANW DB QCOM PCG ACAD RMTI FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:29AM  Investor Alert: Kaplan Fox Announces Investigation Of ACADIA Pharmaceuticals PR Newswire
Jul-31-18 08:00PM  ALERT: Pawar Law Group Announces Investigation of Securities Claims Against ACADIA Pharmaceuticals Inc. - ACAD ACCESSWIRE
05:22PM  CLASS ACTION UPDATE for QCOM, ACAD and TTPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:05PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:22PM  Will ACADIA (ACAD) Disappoint Investors in Q2 Earnings? Zacks
11:27AM  SHAREHOLDER ALERT: COOL UNM ORA FIZZ NWL PCG ACAD RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:15AM  Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed against ACADIA Pharmaceuticals Inc. Business Wire
Jul-30-18 09:00AM  ACADIA Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 8, 2018 Business Wire
Jul-29-18 10:16AM  CLASS ACTION UPDATE for MRCY, MD and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jul-27-18 10:50PM  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD PR Newswire
06:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, QCOM and ACAD GlobeNewswire
05:54PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Pharmaceuticals, Inc. To Contact The Firm GlobeNewswire
01:00PM  IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:12AM  SHAREHOLDER ALERT: MRCY COOL ANW QCOM FIZZ GOGO ACAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:39AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) and Lead Plaintiff Deadline - September 17, 2018 ACCESSWIRE
Jul-26-18 05:08PM  CLASS ACTION UPDATE for FPI, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:23PM  KASKELA LAW LLC: Shareholder Class Action Lawsuit Filed Against ACADIA Pharmaceuticals Inc. Business Wire
04:15PM  RM LAW Announces Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. PR Newswire
03:00PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:15PM  SHAREHOLDER ALERT: ATEN UNM ANW DB GLCNF GLNCY FPI NWL PCG ACAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:31AM  Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against ACADIA Pharmaceuticals Inc. - ACAD PR Newswire
10:23AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Pharmaceuticals Inc. - ACAD ACCESSWIRE
07:35AM  Analysis: Positioning to Benefit within Citigroup, Cinedigm, FS Investment, ACADIA Pharmaceuticals, San Juan Basin Royalty Trust, and Fortress Transportation and Infrastructure Investors Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jul-25-18 06:40PM  IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:45PM  CLASS ACTION UPDATE for FIZZ, ACAD and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:21PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Acadia Pharmaceuticals, Inc. Business Wire
04:17PM  KESSLER TOPAZ MELTZER & CHECK, LLP Announces Investor Securities Fraud Class Action Lawsuit against ACADIA Pharmaceuticals Inc. - ACAD GlobeNewswire
01:53PM  INVESTOR ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:59AM  SHAREHOLDER ALERT: MRCY ATEN QCOM REVG SBGL GOGO ACAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-24-18 07:00PM  Safirstein Metcalf LLP Announces That Class Actions Have Been Filed Against ACADIA Pharmaceuticals, Inc. - ACAD GlobeNewswire
03:55PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:21PM  CLASS ACTION UPDATE for ATEN, REVG and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:12PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Pharmaceuticals Inc. ACAD GlobeNewswire
11:00AM  SHAREHOLDER ALERT: ATEN ANW DB QCOM FPI FIZZ SBGL ACAD FLR REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
11:00AM  Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Acadia Pharmaceuticals Inc. Business Wire
10:22AM  New Securities Class Action Filed Against ACADIA Pharmaceuticals, Inc. (ACAD); Block & Leviton Encourages ACADIA Investors to Contact The Firm PR Newswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ACADIA Pharmaceuticals Inc. (ACAD) and Lead Plaintiff Deadline - September 17, 2018 PR Newswire
Jul-23-18 07:00PM  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD GlobeNewswire
04:50PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ACADIA Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 17, 2018 ACAD GlobeNewswire
04:43PM  Robbins Arroyo LLP: Viability of Acadia Pharmaceuticals, Inc. (ACAD) Drug NUPLAZID Questioned by Recently Filed Class Action Business Wire
12:27PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jul-20-18 04:59PM  Hagens Berman Alerts Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) to the September 17, 2018 Securities Class Action Lead Plaintiff Deadline GlobeNewswire
11:05AM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. ACAD Business Wire
Jul-19-18 09:48PM  Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of ACADIA Pharmaceuticals Inc. Investors (ACAD) Business Wire
05:27PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
04:05PM  ACADIA Pharmaceuticals Announces Appointment of Austin D. Kim as Executive Vice President, General Counsel and Secretary Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ACADIA Pharmaceuticals Inc. (ACAD) PR Newswire
07:45AM  Breakfast Technical Briefing on Avid Bioservices and Three Other Additional Biotech Stocks ACCESSWIRE
Jul-18-18 11:55AM  ACADIA Pharmaceuticals, Inc. (ACAD) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws PR Newswire
08:10AM  Today's Research Reports on Stocks to Watch: AVEO Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE
Jul-17-18 05:34PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire +7.65%
03:36PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against ACADIA Pharmaceuticals Inc. ACAD Business Wire
10:30AM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of ACADIA Pharmaceuticals Inc. Investors (ACAD) Business Wire
Jul-16-18 07:30AM  INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of ACADIA Pharmaceuticals Inc. Investors Business Wire
Jul-13-18 04:08PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of ACADIA Pharmaceuticals Inc. Investors (ACAD) Business Wire
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SOLAND DANIEL BDirectorMar 02Buy22.523,00067,56010,000Mar 02 06:09 PM
SOLAND DANIEL BDirectorMar 01Buy23.917,000167,3507,000Mar 02 06:09 PM
Baity GlennEVP AND GCJan 29Sale32.3936,5581,184,05583,734Jan 31 05:56 PM
Baity GlennEVP AND GCJan 10Option Exercise2.1850,179109,390120,292Jan 11 04:38 PM
Brege LauraDirectorJan 02Option Exercise8.2325,000205,80025,000Jan 04 06:23 PM
Baity GlennEVP AND GCJan 02Option Exercise2.1874,321162,020144,434Jan 04 06:24 PM
Baity GlennEVP AND GCJan 02Sale30.1474,3212,240,13970,113Jan 04 06:24 PM
Brege LauraDirectorJan 02Sale30.0625,000751,5430Jan 04 06:23 PM
BAKER BROS. ADVISORS LPDirectorNov 27Option Exercise1.3839,37854,342491,918Nov 29 04:00 PM
BAKER BROS. ADVISORS LPDirectorOct 13Option Exercise1.381,426,5901,968,69423,763,865Oct 16 05:15 PM
Baity GlennEVP AND GCOct 05Option Exercise1.9128,50054,330107,156Oct 06 06:20 PM
Baity GlennEVP AND GCOct 05Sale40.9137,5001,534,04369,656Oct 06 06:20 PM
Baity GlennEVP AND GCOct 04Option Exercise1.8511,00020,34078,656Oct 06 06:20 PM
Baity GlennEVP AND GCAug 30Option Exercise1.6216,50726,74194,163Sep 01 05:15 PM
Baity GlennEVP AND GCAug 30Sale34.8726,507924,31567,656Sep 01 05:15 PM
open in yahoo | open in reuters | open in google